Literature DB >> 9093353

Commentary: octreotide and hypertrophic pulmonary osteoarthropathy.

R T Penson1, R M Rudd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9093353      PMCID： PMC1758501          DOI： 10.1136/thx.52.3.297

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

1.  Osteoarthropathy in lung cancer: disappearance after section of intercostal nerves.

Authors:  C W HOLMAN
Journal:  J Thorac Cardiovasc Surg       Date:  1963-05       Impact factor: 5.209

2.  Reversal of pulmonary hypertrophic osteoarthropathy by vagotomy.

Authors:  G FLAVELL
Journal:  Lancet       Date:  1956-02-11       Impact factor: 79.321

3.  Octreotide: a potent new non-opiate analgesic for intrathecal infusion.

Authors:  Richard D Penn; Judith A Paice; Jeffrey S Kroin
Journal:  Pain       Date:  1992-04       Impact factor: 6.961

4.  Ectopic growth-hormone production and osteoarthropathy in carcinoma of the bronchus.

Authors:  H Steiner; O Dahlbäck; J Waldenström
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

5.  Somatostatin, a potent analgesic.

Authors:  J Chrubasik; J Meynadier; S Blond; P Scherpereel; E Ackerman; M Weinstock; K Bonath; H Cramer; E Wünsch
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

6.  Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.

Authors:  S A Johnson; P A Spiller; C M Faull
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

7.  Hypertrophic pulmonary osteoarthropathy in association with a bronchial carcinoid tumour.

Authors:  R Bradford; M H Griffiths; P Goldstraw
Journal:  Br J Dis Chest       Date:  1984-07

8.  Bone scintigraphy in growth hormone-secreting pulmonary cancer and hypertrophic osteoarthropathy.

Authors:  H Uchisako; K Suga; N Tanaka; K Nishigauchi; T Matsumoto; N Matsunaga; T Nakanishi
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

9.  Lung cancer containing growth hormone-releasing hormone associated with hypertrophic osteoarthropathy. Case report.

Authors:  H Nomori; R Kobayashi; A Kubo; S Morinaga; Y Shintani; T Sano
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1994
  9 in total
  2 in total

1.  Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

Authors:  Sebastian G Bernardo; Jason J Emer; Mark E Burnett; Marsha Gordon
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 2.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.